Combination long-acting injectable (LAI) antipsychotic medication in adolescents with severe psychosis and aggression: a case series.

Related Articles

Combination long-acting injectable (LAI) antipsychotic medication in adolescents with severe psychosis and aggression: a case series.

Australas Psychiatry. 2018 Nov 26;:1039856218815744

Authors: McInnis P, Kasinathan J

Abstract
OBJECTIVES:: We examine the use of combination long-acting injectable (LAI) antipsychotic medication for adolescents with severe psychosis and aggression. We discuss benefits and risks with this approach, for a highly challenging small group of young people.
METHODS:: A clinical summary is given of three adolescents admitted to a secure adolescent forensic inpatient unit, and the literature is reviewed.
RESULTS:: In these adolescents with severe psychosis, aggression and violent offending, combination LAI antipsychotics effectively treated psychosis and enabled transfer to less restrictive settings. Brief Psychiatric Rating Scale (BPRS) scores decreased significantly with treatment, without any severe adverse effects.
CONCLUSIONS:: Combination LAI antipsychotics may be an effective treatment for adolescents with severe psychosis and aggression where clozapine is not a realistic therapeutic option. Close monitoring for side-effects, clear documentation of clinical reasoning and appropriate safeguards are important.

PMID: 30474388 [PubMed - as supplied by publisher]

Log In